The SIGMA HD-LR Pipe Crawler stands out as the ultimate solution for long-range pipeline inspections, specifically designed to handle distances up to 5,577 feet in a single deployment. This ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

Analyst Joon Lee of Truist Financial maintained a Buy rating on Wave Life Sciences (WVE – Research Report), with a price target of ...

Harmony Biosciences surpassed $2 billion in cumulative net product revenue less than 5 years on the market, highlighting ...

As the calendar approaches the middle of November, a lineup of major companies across various sectors is set to report their ...

Regeneron released a strong financial report for Q3 and was the 15th of 16 in the last four years. Read why I upgrade REGN ...

Despite disappointing third-quarter results for Regeneron’s high-dose Eylea injection, analysts continued to be cautiously ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Third quarter 2024 revenues increased 11% to $3.72 billion versus third quarter 2023Third quarter 2024 Dupixent® global net sales(recorded by ...

providing a strong foundation to expand our wholly owned editing pipeline. We are also advancing WVE-007 for obesity and WVE-N531 for DMD towards key milestones in the first quarter. In HD, we are ...

Third quarter 2024 U.S. net sales for Eylea HD and Eylea increased 3% ... revenue growth and continued investment in our growing pipeline,” said Christopher Fenimore, Senior Vice President ...

Regeneron Pharmaceuticals Inc (REGN) reports an 11% revenue increase, driven by DUPIXENT and EYLEA, while navigating pricing ...